Your browser doesn't support javascript.
loading
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial.
Wu, Jun-Dong; Li, Jing-Xin; Liu, Jian; Wang, Hao-Meng; Zhou, Guang-Hui; Li, Jin; Wu, Dou; Chen, Xiang; Feng, Yan; Qi, Xiao-Yuan; Wang, Xue; Gou, Jin-Bo; Ma, Tie-Liang; Yang, Xiao-Yun; Xu, Li-Feng; Wan, Peng; Zhu, Tao; Wang, Zhong-Fang; Zhu, Feng-Cai.
Afiliación
  • Wu JD; Pulmonary and Critical Care Medicine, Yixing People's Hospital, Yixing, China.
  • Li JX; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China; School of Public Health, Nanjing Medical University, Nanjing, China.
  • Liu J; CanSino Biotechnologies, Shanghai, China; CanSino Biological Research, Shanghai, China; CanSino Biologics, Tianjin, China.
  • Wang HM; CanSino Biotechnologies, Shanghai, China; CanSino Biological Research, Shanghai, China; CanSino Biologics, Tianjin, China.
  • Zhou GH; Pulmonary and Critical Care Medicine, Yixing People's Hospital, Yixing, China.
  • Li J; CanSino Biological Research, Shanghai, China.
  • Wu D; CanSino Biological Research, Shanghai, China.
  • Chen X; Pulmonary and Critical Care Medicine, Yixing People's Hospital, Yixing, China.
  • Feng Y; Pulmonary and Critical Care Medicine, Yixing People's Hospital, Yixing, China.
  • Qi XY; Pulmonary and Critical Care Medicine, Yixing People's Hospital, Yixing, China.
  • Wang X; CanSino Biologics, Tianjin, China.
  • Gou JB; CanSino Biologics, Tianjin, China.
  • Ma TL; Pulmonary and Critical Care Medicine, Yixing People's Hospital, Yixing, China.
  • Yang XY; Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou, China.
  • Xu LF; CanSino Biologics, Tianjin, China.
  • Wan P; CanSino Biologics, Tianjin, China.
  • Zhu T; CanSino Biotechnologies, Shanghai, China; CanSino Biological Research, Shanghai, China; CanSino Biologics, Tianjin, China.
  • Wang ZF; Guangzhou Laboratory, Guangzhou International Bio Island, Guangzhou, China; State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou Medical University, Guangzhou, China. Electronic address: wang
  • Zhu FC; NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China; School of Public Health, Nanjing Medical University, Nanjing, China. Electronic address: jszfc@vip.sina.com.
Lancet Infect Dis ; 23(9): 1020-1030, 2023 09.
Article en En | MEDLINE | ID: mdl-37216958
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Infecciosas del Embarazo / COVID-19 Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Pregnancy País/Región como asunto: Asia Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Infecciosas del Embarazo / COVID-19 Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Pregnancy País/Región como asunto: Asia Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos